Home Details
| Official Symbol of Gene | Ccl5 |
| Species | Mus musculus |
| Entrez Gene ID | 20304 |
| Official Full Name | chemokine (C-C motif) ligand 5 |
| Also known as | SISd; Scya5; RANTES; TCP228; MuRantes |
| Gene Type | protein coding |
| dbXrefs | Ensembl:ENSMUSG00000035042 AllianceGenome:MGI:98262 |
| Map Location | 11 C; 11 50.66 cM |
| Drug | IL-4 therapy(The ependymal route to cytokine-gene therapy) |
| Interaction Type | inhibitor |
| Descent | AB/H mice |
| Disease | EAE |
| Pubmed ID | 11525938 |
| Year | 2001 |
| Title | The ependymal route to the CNS: an emerging gene-therapy approach for MS |
| Result | In the therapeutic protocol, the protection is owing to an in situ downregulation of expression of pro-inflammatory chemokines[e.g. monocyte chemoattractant protein 1 (MCP-1) and regulated on activation normal T-cell expressed and secreted (RANTES)] and cytokines (e.g. IL-1β and TNF-α). |
| Mechanism/pathway | In turn, downregulation of expression of these chemokines and cytokines deactivates macrophages already recruited within the CNS, possibly through the activation of resident microglia. |

2023,CopyRight © HMU. College of Bioinformatics Science and Technology, Harbin, China.